Speech-Language Pathology Supervisor
UMH Speech Pathology
Clinical Assistant Professor of Neurology
[email protected]
Available to mentor
Karen Kluin
Clinical Assistant Professor
-
Brewer GJ, Askari F, Dick RB, Sitterly J, Fink JK, Carlson M, Kluin KJ, Lorincz MT. Transl Res, 2009 Aug; 154 (2): 70 - 77.Journal ArticleTreatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
DOI:10.1016/j.trsl.2009.05.002 PMID: 19595438 -
Brewer GJ, Askari F, Lorincz MT, Carlson M. 2008Journal ArticleTetrathiomolybdate versus Trientine in the Initial Treatment of Neurologic Wilson's Disease
-
Brewer GJ, Askari F, Lorincz MT, Carlson M, Schilsky M, Kluin KJ, Hedera P, Moretti P, Fink JK, Tankanow R, Dick RB, Sitterly J. Arch Neurol, 2006 Apr; 63 (4): 521 - 527.Journal ArticleTreatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
DOI:10.1001/archneur.63.4.521 PMID: 16606763 -
Moretti P, Lieberman AP, Wilde EA, Giordani BI, Kluin KJ, Koeppe RA, Minoshima S, Kuhl DE, Seltzer WK, Foster NL. Neurology, 2004 May 25; 62 (10): 1865 - 1868.Journal ArticleNovel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis.
DOI:10.1212/01.wnl.0000126447.91111.a1 PMID: 15159497 -
Brewer GJ, Hedera P, Kluin KJ, Carlson M, Askari F, Dick RB, Sitterly J, Fink JK. Arch Neurol, 2003 Mar; 60 (3): 379 - 385.Journal ArticleTreatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.
DOI:10.1001/archneur.60.3.379 PMID: 12633149 -
Berent S, Giordani B, Gilman S, Trask CL, Little RJA, Johanns JR, Junck L, Kluin KJ, Heumann M, Koeppe RA. Brain Cogn, 2002 Nov; 50 (2): 194 - 206.Journal ArticlePatterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy.
DOI:10.1016/s0278-2626(02)00503-1 PMID: 12464189 -
Hedera P, Rainier S, Zhao XP, Schalling M, Lindblad K, Yuan Q-P, Ikeuchi T, Trobe J, Wald JJ, Eldevik OP, Kluin K, Fink JK. Neurology, 2002 Feb 12; 58 (3): 411 - 416.Journal ArticleSpastic paraplegia, ataxia, mental retardation (SPAR): a novel genetic disorder.
DOI:10.1212/wnl.58.3.411 PMID: 11839840 -
Jellinger K. Arch Neurol, 2001 Sep; 58 (9): 1499 - 1500.Journal ArticleNeuropathologic correlates of dysarthria in progressive supranuclear palsy.
DOI:10.1001/archneur.58.9.1499 PMID: 11559331